Edition:
United States

People: OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

0.98USD
7 Dec 2018
Change (% chg)

$-0.04 (-3.91%)
Prev Close
$1.02
Open
$1.01
Day's High
$1.03
Day's Low
$0.90
Volume
125,290
Avg. Vol
28,549
52-wk High
$5.15
52-wk Low
$0.90

Lewicki, John 

Dr. John A. Lewicki, Ph.D., is President, Chief Executive Officer, Director of OncoMed Pharmaceuticals, Inc. previously served as our Senior Vice President, Research and Development from 2004. From 1983 to 2000, Dr. Lewicki served in various capacities at Scios, Inc., a public biopharmaceutical company that developed drugs for the treatment of cardiovascular, inflammatory and other diseases, including 12 years as its Vice President of Research, in which capacity he managed the company’s research organization across diverse therapeutic areas. Dr. Lewicki has authored or coauthored over 70 published papers and book chapters and is listed as an inventor on over 30 issued U.S. patents. Dr. Lewicki received a Ph.D. in Physiology/Pharmacology from the University of California, San Diego.

Basic Compensation

Total Annual Compensation, USD 364,727
Restricted Stock Awards, USD 620,600
Long-Term Incentive Plans, USD --
All Other, USD 646,270
Fiscal Year Total, USD 1,759,250

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --